Why is Kilitch Drugs falling/rising?

As of 19-Sep, Kilitch Drugs (India) Ltd is experiencing a decline in its stock price, currently at Rs 355.55, which represents a decrease of Rs 7.8 or 2.15%. The stock has underperformed its sector by 2.42% today and has been on a consecutive downward trend for the last two days, accumulating a total decline of 2.28%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has fallen by 1.33%, and over the past month, it has seen a significant drop of 14.36%, while its year-to-date performance remains positive at 10.08%. Despite the company showing healthy long-term growth in net sales and operating profit, its low return on equity (ROE) of 7.27% and poor management efficiency have raised concerns among investors, contributing to the stock's recent decline.
In the broader market context, Kilitch Drugs has underperformed compared to the Sensex, which has gained 0.88% over the past week. The company's lack of domestic mutual fund investment, which stands at 0%, may indicate a lack of confidence in its current valuation or business prospects. Furthermore, the significant drop in delivery volume by 44.8% against the 5-day average suggests decreasing investor participation, which could further exacerbate the stock's downward movement. Overall, while the company has shown potential for growth, the combination of poor recent performance metrics and investor sentiment has led to the current decline in its stock price.